NCT04027829View on ClinicalTrials.gov

Pharmacokinetics-pharmacodynamics and Safety of Dexmedetomidine in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

November 14, 2019

Study Completion Date

November 14, 2019

Conditions
Intensive Care UnitPostoperative Care
Interventions
DRUG

Dexmedetomidine Hydrochloride

Intravenous infusion of dexmedetomidine at the rate of 0.5mcg/kg for 10 min, then 0.5mcg/kg/hr for 50 min.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Ministry of Food and Drug Safety, Korea

OTHER_GOV

lead

Seoul National University Hospital

OTHER

NCT04027829 - Pharmacokinetics-pharmacodynamics and Safety of Dexmedetomidine in Children | Biotech Hunter | Biotech Hunter